Medinol has received approval from the US Food and Drug Administration (FDA) to sell its PioNIR Plus stent. This is on the basis of the results of a comprehensive trial of the product that was completed a year ago. The PioNIR Plus stent, also sold under the name Presillion Plus, is a stent developed by Medinol for coronary arteries. It is of the ‘bare metal’ type, meaning the stents are not coated with medication.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023

Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023

US Soldiers, Vets To Get Israeli-Made Helmets To Treat Depression
September 27, 2023
Facebook comments